Diagnostic yield of genetic testing in heart transplant recipients with prior cardiomyopathy
暂无分享,去创建一个
H. Heidbuchel | P. Pauwels | B. Loeys | I. Rodrigus | I. Goovaerts | E. V. Van Craenenbroeck | M. Alaerts | A. Vorlat | L. Van Laer | J. Saenen | C. Franssen | P. Pauwels | H. Boen | T. Vermeulen
[1] S. Heymans,et al. Understanding the genetics of adult-onset dilated cardiomyopathy: what a clinician needs to know. , 2021, European heart journal.
[2] K. Musunuru,et al. Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association. , 2020, Circulation. Genomic and precision medicine.
[3] S. Heymans,et al. A mutation update for the FLNC gene in myopathies and cardiomyopathies , 2020, Human mutation.
[4] Shengshou Hu,et al. Multiple genetic variants in adolescent patients with left ventricular noncompaction cardiomyopathy. , 2019, International journal of cardiology.
[5] B. Meiser,et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[6] J. Lopes,et al. Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy. , 2019, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[7] Parth N. Patel,et al. Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy , 2019, Circulation.
[8] D. Judge,et al. Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) , 2018, Genetics in Medicine.
[9] D. O’Regan,et al. Genetic Etiology for Alcohol-Induced Cardiac Toxicity , 2018, Journal of the American College of Cardiology.
[10] S. Cook,et al. Role of titin in cardiomyopathy: from DNA variants to patient stratification , 2018, Nature Reviews Cardiology.
[11] Karen S. Frese,et al. Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy , 2017, European heart journal.
[12] G. Mortier,et al. Targeted Next-Generation Sequencing of 51 Genes Involved in Primary Electrical Disease. , 2017, The Journal of molecular diagnostics : JMD.
[13] P. Ponikowski,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[14] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[15] L. Monserrat,et al. Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation. , 2016, The Journal of Heart and Lung Transplantation.
[16] L. Sugeng,et al. Familial dilated cardiomyopathy diagnosis is commonly overlooked at the time of transplant listing. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[17] J. Seidman,et al. Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. , 2016, The New England journal of medicine.
[18] R. Hershberger,et al. Dilated Cardiomyopathy Overview , 2015 .
[19] D. Roden,et al. Performant Mutation Identification Using Targeted Next‐Generation Sequencing of 14 Thoracic Aortic Aneurysm Genes , 2015, Human mutation.
[20] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[21] K. Sliwa,et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. , 2014, European heart journal.
[22] D. Hedges,et al. Dilated cardiomyopathy: the complexity of a diverse genetic architecture , 2013, Nature Reviews Cardiology.
[23] J. Atherton,et al. Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy , 2013, Genetics in Medicine.
[24] L. Mestroni,et al. Truncations of titin causing dilated cardiomyopathy. , 2012, The New England journal of medicine.
[25] H. Calkins,et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Heart rhythm.
[26] Michael J Ackerman,et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[27] H. Watkins,et al. DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. , 2010, European heart journal.
[28] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.
[29] Stuart Russell,et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[30] A. Tajik,et al. Yield of genetic testing in hypertrophic cardiomyopathy. , 2005, Mayo Clinic proceedings.
[31] J. Svendsen,et al. Heart transplantation in arrhythmogenic right ventricular cardiomyopathy - Experience from the Nordic ARVC Registry. , 2018, International journal of cardiology.
[32] R. Hershberger,et al. Genetic cardiomyopathies , 2018, Current opinion in cardiology.
[33] Jeffrey M. Vinocur,et al. Hereditary arrhythmias and cardiomyopathies: decision-making about genetic testing , 2018, Current opinion in cardiology.
[34] Marilyn M. Li,et al. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. , 2017, The Journal of molecular diagnostics : JMD.
[35] M. Hannan,et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[36] Biykem Bozkurt,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.
[37] S. Jayalakshmi,et al. Peripartum cardiomyopathy. , 1980, Journal of the Indian Medical Association.